These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18807245)

  • 1. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J; Calo G; Guerrini R; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):183-7. PubMed ID: 12595960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes.
    Johnson EE; McDonald J; Nicol B; Guerrini R; Lambert DG
    Brain Res; 2004 Apr; 1003(1-2):18-25. PubMed ID: 15019559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the binding of [(3)H]nociceptin/orphaninFQ(1-13)NH(2), [(3)H]nociceptin/orphaninFQ(1-17)OH and [(125)I]Tyr(14)nociceptin/orphaninFQ(1-17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors.
    Hashiba E; Lambert DG; Farkas J; Toth G; Smith G
    Neurosci Lett; 2002 Aug; 328(1):5-8. PubMed ID: 12123846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
    Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J; Barnes TA; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
    Eur J Pharmacol; 2002 May; 443(1-3):7-12. PubMed ID: 12044785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH (2).
    Kitayama M; McDonald J; Barnes TA; Calo' G; Guerrini R; Rowbotham DJ; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):369-76. PubMed ID: 17598088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor.
    McDonald J; Lambert DG
    Br J Pharmacol; 2010 Mar; 159(6):1286-93. PubMed ID: 20148892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
    Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
    Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
    Arduin M; Spagnolo B; Calò G; Guerrini R; Carrà G; Fischetti C; Trapella C; Marzola E; McDonald J; Lambert DG; Regoli D; Salvadori S
    Bioorg Med Chem; 2007 Jul; 15(13):4434-43. PubMed ID: 17490886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.
    Fischetti C; Camarda V; Rizzi A; Pelà M; Trapella C; Guerrini R; McDonald J; Lambert DG; Salvadori S; Regoli D; Calo' G
    Eur J Pharmacol; 2009 Jul; 614(1-3):50-7. PubMed ID: 19445927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of nociceptin/orphanin FQ binding sites in dog brain membranes.
    Johnson EE; Gibson H; Nicol B; Zanzinger J; Widdowson P; Hawthorn M; Toth G; Farkas J; Guerrini R; Lambert DG
    Anesth Analg; 2003 Sep; 97(3):741-747. PubMed ID: 12933394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.